سعر ازجوميكسول 1% قطرة 5 مل 2022

Rimexolone 1% eye drops, 5 ml bottle; ophthalmic corticosteroid (Grand Pharma for APIC, Egypt).

• Postoperative inflammation following ocular surgeryPopulation: AdultsHealth Products Regulatory Authority (HPRA), Ireland
• Anterior uveitisPopulation: AdultsHealth Products Regulatory Authority (HPRA), Ireland
• Steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe (non-infectious)Population: AdultsHealth Products Regulatory Authority (HPRA), Ireland

• Common adverse reactions (about 1-2%): blurred vision, eye discharge and ocular discomfort; uncommon: keratitis, increased intraocular pressure and other ocular reactions.International label, equivalent formulation · Health Products Regulatory Authority (HPRA), Ireland

• Hypersensitivity to the active substance or excipients; epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, varicella and other viral diseases of the cornea and conjunctiva; mycobacterial or fungal infections of the eye; acute purulent untreated eye infections; red eye not diagnosed; amoebic (e.g. Acanthamoeba) eye infections.International label, equivalent formulation · Health Products Regulatory Authority (HPRA), Ireland

• Prolonged use of ophthalmic corticosteroids may cause ocular hypertension/glaucoma with optic nerve damage, reduced visual acuity and visual field defects, and posterior subcapsular cataract; monitor IOP frequently, especially in children and in patients with glaucoma or predisposition.International label, equivalent formulation · Health Products Regulatory Authority (HPRA), Ireland
• Corticosteroids may reduce resistance to and mask or aggravate ocular infections (bacterial, viral, fungal); fungal keratitis should be considered with persistent corneal ulceration. In diseases causing thinning of the cornea or sclera, perforation may occur. Topical corticosteroids may delay corneal wound healing (topical NSAIDs may add to this).International label, equivalent formulation · Health Products Regulatory Authority (HPRA), Ireland

• Topical NSAIDs (ophthalmic)Concomitant use with topical steroids may increase the potential for corneal healing problems.Health Products Regulatory Authority (HPRA), Ireland
• Other topical ophthalmic medicinesAdminister at least 5 minutes apart.Health Products Regulatory Authority (HPRA), Ireland

• Should not be used during pregnancy unless clearly necessary; infants born to mothers who received substantial corticosteroid doses during pregnancy should be observed carefully for signs of hypoadrenalism.International label, equivalent formulation · Health Products Regulatory Authority (HPRA), Ireland
• Unknown whether topical rimexolone is excreted in human milk; a decision must be made whether to discontinue breastfeeding or discontinue therapy, taking into account the benefit of breastfeeding for the child and of therapy for the woman.International label, equivalent formulation · Health Products Regulatory Authority (HPRA), Ireland

• Rimexolone: Corticosteroid that suppresses the inflammatory response to mechanical, chemical or immunological agents (oedema, fibrin deposition, capillary dilation, leucocyte migration) (Vexol SmPC).